Volume 3, Issue 3 (spring 2017)                   2017, 3(3): 78-90 | Back to browse issues page

XML Persian Abstract Print


shahrekord university of medical sciences , rafiee.leila@yahoo.com
Abstract:   (6277 Views)
Introuduction and pourpse  : relan failure and hemodialysisi are common treatment in choronic disease. One of the problems that have been reported in patients to this patients is level adherence to treatment . The aim of this study was to determine the status of adherence to treatment and dialysis adequacy in hemodialysis patients referred to dialysis centers Hajar hospital of Shahrekord.
Materials and Methods: In this cross-sectional study in 2013, 43 hemodialysis patients were selected based approach. Demographic and laboratory data using a questionnaire and adherence with treatment of patients in end-stage renal failure (ESRD-AQ) was collected. Information obtained by using descriptive and inferential statistical tests such as chi-square analysis was used.
Findings  : The results of this study showed that the mean age of the patients participating in the study was 69/47 ± 4/67 years. Average years of dialysis patients was 4/00 ± 6/33. Average overall adherence to therapy in these patients was1465/21 ± 225/34 . 69/8% of patients in terms of overall compliance dialysis treatment at the medium level. 2/65% of these patients regarding medication adherence, 79/1% of patients in terms of adherence to fluid restriction, 81/4% in terms of adherence to dietary restriction and 90/7% of adherence of dialysis in were average.
Conclusion: The results of this study, adherence to treatment of patients was moderate, possibly chronic illness, economic hardship of living and lack of awareness of these patients; therefore, pay more attention to the causes of poor treatment adherence in hemodialysis patients It is necessary.
 
Full-Text [PDF 161 kb]   (1939 Downloads)    
Type of Study: Research | Subject: Special
Received: 2017/04/15 | Accepted: 2017/06/10 | Published: 2017/06/17

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.